InnerScope Partners with Ainnova Tech in OTCHealth Acquisition
InnerScope Hearing Technologies announced its participation in the acquisition of OTCHealth Inc. by Ainnova Tech, Inc., according to a press release. The partnership allows InnerScope to leverage its retail distribution network and technology portfolio to enhance access to preventive hearing and health solutions.
As an equity owner in OTCHealth, InnerScope will transfer most of its sales operations, including retail agreements with major U.S. outlets such as Walmart, CVS, Target, and Walgreens, to OTCHealth. The move will enable OTCHealth, now a subsidiary of Ainnova, to expand its reach across more than 15,000 independent pharmacies and healthcare providers nationwide.
Under the agreement, InnerScope will hold equity and profit participation in both OTCHealth and Ainnova following the acquisition. The company will focus on advancing its proprietary hearing technologies, which will be integrated into OTCHealth’s digital health offerings supported by Ainnova’s AI-driven diagnostics platform.
The collaboration aims to combine InnerScope’s hearing care expertise, OTCHealth’s digital health infrastructure, and Ainnova’s AI-based analytics to improve early detection of conditions linked to hearing loss, such as diabetes and cognitive decline.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly, AI Funding Brief or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 13 Bracco and Avicenna.AI win FDA clearance for AI that flags brain aneurysms on CT scans Nov 13 Zus Health raises $33 million to build the data layer for healthcare AI Nov 13 Google DeepMind releases AlphaGenome 2 to predict DNA variant effects in specific cell types Nov 13 Taiwan hospital accelerator T+ MedIC names AI ECG and CT screening tools as first winners Nov 13 Sheinbaum meets OpenAI president Greg Brockman on AI in Mexican healthcareMore from Funding
Nov 13 Polar DC adds Palistar financing as 2026 commitments pass EUR 1 billion Nov 13 Peter Sarlin's PostScriptum takes majority stake in Finnish AI deployment firm Brillian Nov 13 MISTT raises £5 million to build a space-and-time data layer for AI and autonomous systems Nov 13 Zus Health raises $33 million to build the data layer for healthcare AI Nov 12 Inveniam acquires Docugami, the document AI startup of XML pioneer Jean PaoliLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
ELEHEAR Wins Two 2026 Hearing Technology Awards
Revive Health and FitOn Health Combine Into AI Healthcare Platform
Eko Health Launches CORE 300 AI Stethoscope
Oura to Buy AI Care Company Counsel Health for $625 Million
AstraZeneca and Oracle Partner on AI for Clinical Trials
Daily AI Brief: the AI news that matters, in your inbox.